Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Social media exposure linked to increased cannabis, dual substance use in adolescents
Frequent exposure to cannabis and e-cigarette posts on social media is linked to increased teen cannabis and dual substance use, according to a study published in JAMA.
ADHD Medications: A Look at Their Safety Profile
Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
In this video interview, Michael Daines, MD, explains phase 3 data for Panzyga (Octapharma) for pediatric acute- onset neuropsychiatric syndrome (PANS).
Artificial intelligence improves accuracy in estimating child abuse
New model refines prevalence estimates, reduces misdiagnoses compared to the current coding system.
CBD may ease autism symptoms in children
CBD cannabis extract may improve social responsiveness and reduce disruptive behavior in children with autism, with no increase in adverse effects, according to a recent study
Q1 2025: A recap of the top headlines and interviews
View our Q1 2025 recap of standout pediatric news from FDA regulatory updates, clinical trial results, and expert commentary.